Christopher Nutting, MD

home / authors / christopher-nutting,-md

Articles

Dysphagia-Optimized IMRT Shows Significance in Head and Neck Cancer

Dysphagia-Optimized IMRT Shows Significance in Head and Neck Cancer

July 15th 2020

Christopher Nutting, MD, discusses the results of a randomized phase 3 trial using dysphagia-optimized intensity modulated radiotherapy versus standard IMRT in patients with head and neck cancer.